DT Editorial Team

The Developments Today editorial team curating and writing technology, science, and engineering news.

Articles

Washington State University has developed a wearable biosensor using microneedle technology that measures glucose in interstitial fluid with superior accuracy and comfort compared to conventional continuous glucose monitoring systems.
The device transmits real-time glucose data wirelessly to smartphones, enabling patients to make immediate adjustments to diet, medication, and activity rather than relying on delayed information.
Ultra-fine microneedles penetrate only outer skin layers, significantly reducing discomfort and potentially improving patient compliance for those requiring multiple daily glucose checks.
The biosensor demonstrates exceptional accuracy across the physiological glucose range relevant to diabetes management, a critical requirement for clinical adoption and patient safety.

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

Researchers have developed an AI system that uses optical coherence tomography (OCT) imaging to identify lipid-rich plaques in coronary arteries, offering a breakthrough tool for detecting dangerous lesions before they cause heart attacks.
Lipid-rich plaques are particularly dangerous because they rupture easily and cause acute myocardial infarction, yet traditional angiography cannot characterize their internal composition—a critical diagnostic gap the new AI system addresses.
OCT imaging provides superior micrometer-level resolution compared to conventional X-ray angiography, but generates hundreds of frames per scan that are time-consuming for manual analysis; machine learning algorithms now automate this interpretation with high accuracy.
The AI platform rapidly processes entire OCT datasets to identify subtle visual patterns and morphological features associated with plaque vulnerability, reducing diagnostic variability and interpretive burden on cardiologists.

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

A Neurology study found that traumatic brain injury survivors across all severity levels—from mild concussions to severe cases—face substantially elevated work disability risks extending up to five years post-injury, challenging the conventional focus on severe cases only.
The five-year follow-up period revealed that workers who appeared to recover adequately during early rehabilitation phases continued experiencing persistent employment barriers years later, highlighting the need for extended support beyond acute recovery phases.
Mild traumatic brain injuries produced disability qualification rates comparable to moderate and severe injuries, suggesting that post-concussion symptoms like cognitive difficulties, headaches, and mood changes accumulate to significantly impair workplace function despite minimal structural brain damage on imaging.

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

Rice University researchers developed the first comprehensive, label-free molecular atlas of Alzheimer's-affected brain tissue, using innovative imaging that eliminates the need for fluorescent tags or radioactive markers and reveals biological processes in their natural state.
The molecular mapping identified specific metabolic pathways showing abnormal activity patterns in diseased brains, revealing that Alzheimer's involves far more complex biochemical disruptions than previously understood.
These metabolic discoveries point to new therapeutic intervention points, potentially enabling the development of treatments designed to restore normal biochemical function and interrupt disease progression in affected brain regions.
The research underscores the urgency of Alzheimer's research, as the disease claims more lives annually than breast cancer and prostate cancer combined, making breakthrough discoveries critical for earlier detection and more effective interventions.

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

Researchers from McMaster, Flinders, and Greifswald universities identified the cause of vaccine-induced thrombotic thrombocytopenia (VITT): the immune system mistakenly attacks blood platelets and clotting factors instead of the adenoviral vaccine vector.
The condition affects only a small subset of individuals with specific genetic or immunological predispositions, suggesting that susceptibility to this rare complication depends on individual immune system characteristics rather than the vaccine itself.
Understanding this immune misdirection mechanism is critical for improving future vaccine design, managing affected patients, and predicting similar risks with upcoming immunizations while maintaining confidence in life-saving vaccines.

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

DT Editorial Team·Feb 22, 2026·4 min read·via medicalxpress.com

DT Editorial Team·Feb 22, 2026·4 min read·via wired.com